Skip to main content
SpringerLink
Log in

Interaction between inflammation-related gene polymorphisms and cigarette smoking on the risk of myocardial infarction in the Physician’s Health Study

  • Original Investigation
  • Published:
Human Genetics Aims and scope Submit manuscript

Abstract

Inflammation is known to be a major component of atherosclerosis, and cigarette smoking is known to induce a systemic inflammatory response. We therefore, investigated possible gene–environment interactions between various inflammation-related gene polymorphisms and cigarette smoking on the risk of myocardial infarction (MI) in the Physician’s Health Study (PHS), a cohort of initially healthy middle-aged men. We used a nested case-control design consisting of 522 MI cases and 2,089 controls derived from PHS. Eleven inflammatory polymorphisms were studied using logistic regression analysis: eotaxin (ala23thr), intercellular adhesion molecule 1 (gly241arg), interleukin-4 (582C>T), interleukin-4 receptor (ile75val, gln576arg), interleukin-6 (−174G>C), interleukin-10 (−571C>A), P-selectin (val640leu, thr756pro, ser330asn), and vascular cell adhesion molecule 1 (−1594T>C). Interactions of smoking with all the three modes of inheritance (additive, dominant, recessive) were tested. Statistically significant (P<0.05) interaction terms were found for interleukin-4 receptor (ile75val), with odds ratios of 0.52 (95%CI:0.29–0.95) for Ile–Val and 0.34 (95%CI:0.14–0.83) for Val-Val, compared to the wildtype Ile-Ile; for interleukin-6 (−174G>C) with odds ratios of 2.16 (1.14–4.09) for GC and 0.81 (0.31–2.12) for CC, compared to the wildtype GG; and for P-selectin (ser330asn) with odds ratios of 0.48 (0.24–0.95) for Ser-Asn and 1.08 (0.29–3.93) for Asn-Asn, compared to the wildtype Ser-Ser, with these effects occurring only among the smokers. These data raise the possibility of interaction between the smoking status and certain inflammatory polymorphisms on the risk of MI in men. However, these results should be interpreted with caution due to the potential for false positive results that can arise from analyses with multiple comparisons.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Barbaux SC, Blankenberg S, Rupprecht HJ, Francomme C, Bickel C, Hafner G, Nicaud V, Meyer J, Cambien F, Tiret L (2001) Association between P-selectin gene polymorphisms and soluble P-selectin levels and their relation to coronary artery disease. Arterioscler Thromb Vasc Biol 21:1668–1673

    Article  PubMed  CAS  Google Scholar 

  • Basso F, Lowe GD, Rumley A, McMahon AD, Humphries SE (2002) Interleukin-6 −174G>C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). Arterioscler Thromb Vasc Biol 22:599–604

    Article  PubMed  CAS  Google Scholar 

  • Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 57:289–300

    Google Scholar 

  • Bermudez EA, Rifai N, Buring JE, Manson JE, Ridker PM (2002) Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 89:1117–1119

    Article  PubMed  Google Scholar 

  • Byron K, Varigos G, Wootton A (1994) Il-4 production is increased in cigarette smokers. Clin Exp Immunol 95:333–336

    PubMed  CAS  Google Scholar 

  • Carter AM, Anagnostopoulou K, Mansfield MW, Grant PJ (2003) Soluble p-selectin levels, p-selectin polymorphisms and cardiovascular disease. J Thromb Haemost 1:1718–1723

    Article  PubMed  CAS  Google Scholar 

  • Devlin B, Risch N (1995) A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29:311–322

    Article  PubMed  CAS  Google Scholar 

  • Dong ZM, Chapman SM, Brown AA, Frenette PS, Hynes RO, Wagner DD (1998) The combined role of P- and E-selectins in atherosclerosis. J Clin Invest 102:145–52

    Article  PubMed  CAS  Google Scholar 

  • Donger C, Georges JL, Nicaud V, Morrison C, Evans A, Kee F, Arveiler D, Tiret L, Cambien F (2001) New polymorphisms in the interleukin-10 gene–relationships to myocardial infarction. Eur J Clin Invest 31:9–14

    Article  PubMed  CAS  Google Scholar 

  • Georges JL, Loukaci V, Poirier O, Evans A, Luc G, Arveiler D, Ruidavets JB, Cambien F, Tiret L (2001) Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Temoin de l’Infarctus du Myocarde J Mol Med 79:300–5

    CAS  Google Scholar 

  • Hackstein H, Heckler M, Kruse S, Bohnert A, Ober C, Deichmann K, Bein G (2001) A novel polymorphism in the 5′ promoter region of the human interleukin-4 receptor alpha-chain gene is associated with decreased soluble interleukin-4 receptor protein levels. Immunogenetics 53:264–269

    Article  PubMed  CAS  Google Scholar 

  • Haley KJ, Lilly CM, Yang JH, Feng Y, Kennedy SP, Turi TG, Thompson JF, Sukhova GH, Libby P, Lee RT (2000) Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation 102: 2185–2189

    PubMed  CAS  Google Scholar 

  • Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, Simoons ML, Zeiher AM, Investigators CS (2003) Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107:2109–2114

    Article  PubMed  CAS  Google Scholar 

  • Herrmann SM, Ricard S, Nicaud V, Mallet C, Evans A, Ruidavets JB, Arveiler D, Luc G, Cambien F (1998) The P-selectin gene is highly polymorphic: reduced frequency of the Pro715 allele carriers in patients with myocardial infarction. Hum Mol Genet 7:1277–1284

    Article  PubMed  CAS  Google Scholar 

  • Hershey GKK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA (1997) The Association of Atopy with a Gain-of-Function Mutation in the alpha Subunit of the Interleukin-4 Receptor. N Engl J Med 337:1720–1725

    Article  PubMed  CAS  Google Scholar 

  • Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ (2001) The interleukin-6 −174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 22:2243–2252

    Article  PubMed  CAS  Google Scholar 

  • Hwang S, Ballantyne C, AR S (1997) Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 96:4219–4225

    PubMed  CAS  Google Scholar 

  • Jenny NS, Tracy RP, Ogg MS, Luong le A, Kuller LH, Arnold AM, Sharrett AR, Humphries SE (2002) In the elderly, interleukin-6 plasma levels and the −174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol 22:2066–2071

    Article  PubMed  CAS  Google Scholar 

  • Kovanen P, Manttari M, Palosuo T, Mannienen V, Aho K (1998) Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M. Arch of Intern Med 158:1434–1439

    Article  CAS  Google Scholar 

  • Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105:1135–1143

    Article  PubMed  CAS  Google Scholar 

  • de Maat MP, Kluft C (2002) The association between inflammation markers, coronary artery disease and smoking. Vas Pharmacol 39:137–139

    Article  Google Scholar 

  • Mitsuyasu H, Izuhara K, Mao X, Gao P, Arinobu Y, Enomoto T, Kawai M, Sasaki S, Dake Y, Hamasaki N, Shirakawa T, Hopkin J (1998) Ile50val variant of IL4Ralpha upregulates IgE synthesis and associates with atopic asthma. Nat Genet 19:119–120

    Article  PubMed  CAS  Google Scholar 

  • Nauck M, Winkelmann BR, Hoffmann MM, Bohm BO, Wieland H, Marz W (2002) The interleukin-6 G(−174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction. J Mol Med 80: 507–513

    Article  PubMed  CAS  Google Scholar 

  • Niiro H, Otsuka T, Izuhara K, Yamaoka K, Ohshima K, Tanabe T, Hara S, Nemoto Y, Tanaka Y, Nakashima H, Niho Y (1997) Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils. Blood 89: 1621–1628

    PubMed  CAS  Google Scholar 

  • Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J (1998) Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351:88–92

    Article  PubMed  CAS  Google Scholar 

  • Ridker P, Rifai N, Stampfer M, Hennekens C (2000) Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767–1772

    PubMed  CAS  Google Scholar 

  • Ridker P, Buring J, Rifai N (2001) Soluble P-selectin and the risk of future cardiovascular events. Circulation 103:491–495

    PubMed  CAS  Google Scholar 

  • Wallenstein S, Hodge S, Weston A (1998) Logistic regression model for analyzing extended haplotype data. Genet Epidemiol 15:173–181

    Article  PubMed  CAS  Google Scholar 

  • Wang XL, Raveendran M, Wang J (2003) Genetic influence on cigarette-induced cardiovascular disease. Progr Cardiovas Dis 45:361–382

    CAS  Google Scholar 

  • Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V (2000) Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 148:209–214

    Article  PubMed  CAS  Google Scholar 

  • Zee R, Cook N, Cheng S, Erlich H, Lindpaintner K, Lee R, Ridker P (2004a) Threonine for alanine substitution in the eotaxin (CCL11) gene and the risk of incident myocardial infarction. Atherosclerosis 175:91–94

    Article  CAS  Google Scholar 

  • Zee RYL, Cook NR, Cheng S, Reynolds R, Erlich HA, Lindpaintner K, Ridker PM (2004b) Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis. Hum Mol Genet 13:389–396

    Article  CAS  Google Scholar 

Download references

Acknowledgement

Funding for this project was obtained from the Donald W. Reynolds Foundation, Las Vegas, NV, USA.

Author information

Authors and Affiliations

  1. Dept. of Epidemiology, Harvard School of Public Health Kresge 911, 677 Huntington Avenue, Boston, MA, 02115, USA

    Sarah A. Rosner

  2. Division of Preventive Medicine, Brigham and Women’s Hospital, Boston, MA, USA

    Sarah A. Rosner, Paul M. Ridker, Robert Y. L. Zee & Nancy R. Cook

  3. Center for Cardiovascular Disease Prevention and the Donald W. Reynolds Center for Cardiovascular Research, Brigham and Women’s Hospital, Boston, MA, USA

    Paul M. Ridker, Robert Y. L. Zee & Nancy R. Cook

Authors
  1. Sarah A. Rosner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul M. Ridker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert Y. L. Zee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nancy R. Cook
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarah A. Rosner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosner, S.A., Ridker, P.M., Zee, R.Y.L. et al. Interaction between inflammation-related gene polymorphisms and cigarette smoking on the risk of myocardial infarction in the Physician’s Health Study. Hum Genet 118, 287–294 (2005). https://doi.org/10.1007/s00439-005-0052-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00439-005-0052-6

Keywords

Search

Navigation